期刊文献+

盐酸帕洛诺司琼对预防含顺铂方案化疗所致恶心呕吐患者的疗效观察 被引量:9

Effect observation of Palonosetron hydrochloride on preventing nausea and vomiting with chemotherapy including cisplatin
下载PDF
导出
摘要 目的探讨分别应用盐酸帕洛诺司琼、盐酸格拉司琼预防含顺铂方案化疗所致恶心呕吐的疗效。方法将60例接受含顺铂方案化疗的肿瘤患者随机分为观察组(盐酸帕洛诺司琼组)及对照组(盐酸格拉司琼组),每组各30例,比较两组对预防化疗所致呕吐的临床疗效、用药后不同时间恶心的完全控制率以及恶心治疗后的有效率。结果观察组急性呕吐的总有效率(83.3%)明显高于对照组(66.7%),两组延迟性呕吐的总有效率分别为70.0%和53.3%,差异有统计学意义(χ2=14.127,P<0.05)。用药后的第7天,第15天,观察组恶心的完全控制率明显高于对照组(χ2=6.237、11.248,P<0.05)。用药后第15天,观察组对恶心治疗的有效率明显高于对照组(χ2=12.469,P<0.05)。两组不良反应比较无显著性差异(P>0.05)。结论盐酸帕洛诺司琼在预防含顺铂方案化疗所引起的恶心呕吐的疗效优于盐酸格拉司琼,安全性好,值得临床推广。 Obejective To investigate and compare effects of Palonosetron hydrochloride and granisetron hydrochloride were used to prevent the nausea and vomiting caused by chemotherapy with cisplatin.Methods 60 patients receiving chemotherapy including cisplatin were randomly divided into the observation group(palonosetron hydrochloride Group)and the control group(granisetron hydrochloride group),each group contained 30 cases.The occurrence of acute emesis,delayed vomiting,and Nausea complete control rate,nausea treatment efficiency after treatment different times were compared between two groups.Results The acute vomiting total effective rate in observation group(83.3%) was significantly higher than the control group(66.7%).Delayed vomiting total efficiency of two groups was 70.0% and 53.3% respectively,the difference was statistically significance(χ2=14.127,P 0.05).After medication 7 days,15 days,the full control of nausea rate in the observation group was significantly higher than the control group(χ2=6.237,11.248,P 0.05).After Medication 15 days,the efficacy rate for nausea treatment in the observation group was significantly higher than the control group(χ2=12.469,P 0.05).Two sets of adverse reactions was no significant difference(P 0.05).Conclusion The efficacy of Palonosetron hydrochloride in the prevention and treatment of nausea and vomiting caused by chemotherapy including cisplatin is superior to the efficacy of aranisetron hydrochloride,and Palonosetron hydrochloride has its own priorities,such as convenient use,good safety and worthy of clinical application.
作者 段琼玉 吴荣
出处 《中国医药导报》 CAS 2012年第16期45-46,49,共3页 China Medical Herald
关键词 盐酸帕洛诺司琼 盐酸格拉司琼 化疗 恶心 呕吐 Palonosetron Granisetron Chemotherapy Nausea Vomiting Quality of life
  • 相关文献

参考文献6

二级参考文献41

  • 1王海凤,王东凯.5-HT_3受体阻滞剂帕洛诺司琼[J].中国新药杂志,2006,15(10):833-835. 被引量:16
  • 2赵忠斌,魏振平,芮伟.化疗止吐临床治疗药物新进展[J].世界临床药物,2006,27(8):480-484. 被引量:35
  • 3左怀荣.盐酸帕诺洛司琼[J].齐鲁药事,2007,26(3):190-190. 被引量:3
  • 4陈映霞,秦叔逵,程颖,陈振东,李进,张清媛,潘良熹.盐酸帕洛诺司琼预防化疗性恶心呕吐的多中心双盲随机对照临床研究[J].临床肿瘤学杂志,2007,12(3):161-165. 被引量:48
  • 5高纯颖,童晓青,徐峰.5-HT_3受体拮抗剂抑制化疗致吐的研究进展[J].沈阳药科大学学报,2007,24(4):254-258. 被引量:13
  • 6Aapro M S. Palonosetron as an anti-emetic and anti nausea agent in oncology[J]. Ther Clin Risk Manag, 2007,3(6):1009-1020.
  • 7Gralla R, Lichinitser M, Van der Vegt S, et al. Palonosetron improves prevention of chemotherapy induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double blind randomized phase Ⅲ trial comparing single doses of palonosetron with ondansetron [J]. Ann Oncol, 2003, 14(10):1570-1577.
  • 8Aapro M S, Grunberg S M, Manikhas G M, etal. A phase Ⅲ, double blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly ernetogenic chemotherapy[J]. Ann Oncol, 2006, 17(9): 1441-1449.
  • 9Sepulveda Vidosola A C, Betanzos-Cabrera Y, Lastiri G G, et al. Palonosetron hydroehloride is an effective and safe option to prevent ehemotherapy-indueed nausea and vomiting in children[J]. Arch Med Res, 2008, 39(6):601-606.
  • 10Eisenberg P, Figueroa-Vadillo J, Zamora R, et al. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel5-HT3 receptor antagonist[J]. Cancer, 2003,98(11): 2473-2482.

共引文献63

同被引文献78

引证文献9

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部